PSA ed età

Abstract

166 patients between 50-86 years old have been examimed for PSA immunoenzymatical determination (prostatic specific antigen). This group of patients has been divided into classes according to age (50-60, 61-70, 71-80) and urological pathology (107 with benign prostatic hypertrophy; 12 with histologically defined prostatic carcinoma without therapy; 15 with prostatic carcinoma incidentally determined after prostatic adenomectomy for benign prostatic hypertrophy and 32 patients with no prostatic urological pathology). We wanted to investigate how the PSA is correlated with age. The results of this study could demonstrate the importance of age for PSA interpretation. The low sensibility of this marker for the diagnosis of prostatic incidental carcinoma and low-class prostatic carcinoma could be shown with this study.